Get the Stockscreener App
6.01
2.91%
-0.18
Alpha Cognition Inc stock is traded at $6.01, with a volume of 15,938.
It is down -2.91% in the last 24 hours and down -19.65% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$6.19
Open:
$6.13
24h Volume:
15,938
Relative Volume:
0.19
Market Cap:
$129.38M
Revenue:
-
Net Income/Loss:
$-14.72M
P/E Ratio:
-2.1237
EPS:
-2.83
Net Cash Flow:
$-7.41M
1W Performance:
-10.16%
1M Performance:
-19.65%
6M Performance:
-5.95%
1Y Performance:
+0.00%
1-Day Range:
$5.96
$6.245
1-Week Range:
$5.905
$6.9499
52-Week Range:
$3.75
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1200-750 W PENDER ST, VANCOUVER
Compare ACOG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
6.1609 | 129.38M | 0 | -14.72M | -7.41M | -2.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.02 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.18 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.84 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Can Alpha Cognition Inc. stock deliver strong Q4 earningsTrade Signal Summary & Safe Capital Allocation Plans - newser.com
Alpha Cognition Inc. stock trend forecastQuarterly Performance Summary & Long-Term Safe Return Strategies - newser.com
Is Alpha Cognition Inc. stock attractive for passive investors2025 Volume Leaders & Growth Focused Entry Reports - newser.com
Can Alpha Cognition Inc. recover in the next quarterMarket Risk Report & Reliable Volume Spike Alerts - newser.com
Applying big data sentiment scoring on Alpha Cognition Inc.Bear Alert & Fast Gain Swing Alerts - newser.com
Custom watchlist performance reports with Alpha Cognition Inc.Market Activity Report & Real-Time Market Trend Scan - newser.com
Is Alpha Cognition Inc. stock a smart buy before Fed meeting2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Can Alpha Cognition Inc. stock surprise with earnings upside2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Real time breakdown of Alpha Cognition Inc. stock performanceMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
Published on: 2025-10-31 05:48:11 - newser.com
Alpha Cognition Inc.'s (NASDAQ:ACOG) market cap dropped US$17m last week; Retail investors bore the brunt - simplywall.st
Will Alpha Cognition Inc. stock benefit from sector rotationCEO Change & Smart Swing Trading Alerts - newser.com
Is Alpha Cognition Inc. stock gaining market shareWeekly Stock Recap & Free Community Consensus Stock Picks - newser.com
Is Alpha Cognition Inc. stock attractive for long term wealth buildingIndex Update & Low Risk High Reward Ideas - newser.com
Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025 - BioSpace
Alpha Cognition Stock Dropped 6.2%Have You Assessed the Risk - Trefis
Is Alpha Cognition Inc. stock resilient to inflation2025 Technical Overview & Low Risk Profit Maximizing Plans - fcp.pa.gov.br
Will Alpha Cognition Inc. stock pay special dividendsTrade Signal Summary & Community Supported Trade Ideas - fcp.pa.gov.br
Panic Selling: How Alpha Cognition Inc. stock compares to industry benchmarksWeekly Market Outlook & High Win Rate Trade Alerts - fcp.pa.gov.br
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alpha Cognition Inc Stock (ACOG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MERTZ PHILLIP JOSEPH | Director |
Aug 18 '25 |
Sale |
9.00 |
27,778 |
250,002 |
22,462 |
| MERTZ LEONARD POWELL | Director |
Aug 18 '25 |
Buy |
9.00 |
27,778 |
250,002 |
121,503 |
| McFadden Michael E. | Chief Executive Officer |
Nov 13 '24 |
Buy |
5.75 |
2,608 |
14,996 |
14,142 |
| MERTZ LEONARD POWELL | Director |
Nov 13 '24 |
Buy |
5.75 |
8,695 |
49,996 |
93,725 |
| HAVENS JOHN PRENTISS | Director |
Nov 13 '24 |
Buy |
5.75 |
4,347 |
24,995 |
273,272 |
0.03%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):